On 14 October Royce in collaboration with REGENHU, ran a half day event to provide updates on the latest developments around 3D Bioprinting for Tissue Engineering (TE) and Regenerative Medicine (RM) applications.
Speakers from academia and industry outlined their experiences, including the challenges and opportunities associated with the application of 3D Bioprinting, alongside training on Computer-Aided Design (CAD) and 3D Bioprinting of biological constructs.
Over 270 delegates from the Tissue Engineering and Regenerative Medicine Research community across academia and industry joined the event in a virtual setting.
Professor David Knowles, Royce CEO, began the day by setting out the Royce Vision, followed by Dr Jonny Blaker, Research Area Lead for Royce Biomedical Materials who spoke about Royce’s Vision for Biomedical Materials and Dr Ian Wimpenny, Royce Research and Facilities Manager, who showcased the bioprinting facilities available at Royce
Thanks also go to keynotes Dr Miguel Castillo, Assistant Professor at Utrecht University for his spotlight on Multitechnology Biofabrication, and unlocking the challenges of functional tissue manufacturing and Dr Maïté Rielland, Advanced Research Engineer, L’Oréal who shone a light on the promises and future of epidermis Bioprinting in cosmetic evaluation.
Dr. Samuel Moxon, Postdoc Research Associate in the Division of Cell Matrix Biology & Regenerative Medicine at Manchester provided us with insights into printing in suspension – gels, microstructures and tissue analogues.
The morning sessions were followed up by comprehensive streamed training sessions from REGENHU headquarters in Switzerland on 3D Bioprinting from both a software and hardware perspective.
Dr Marco Domingos, Senior Lecturer in Bioprinting and Regenerative Medicine and Principal Investigator, Royce, who facilitated the event, said: “We organised this event when there were still COVID limitations on in person events, but attendees said that they had really appreciated getting up close and experiencing RegenHu 3D Bioprinting kit live in a virtual setting. It also allowed us to bring in an international audience and to build a growing community in this key research area for Royce.”
A survey at the close of the event showed that the majority of the online delegates were still at any early stage of their career, followed closely by those who are gaining a degree of competency. The majority found the training helpful or very helpful in relation to their own research project, and over 80% said they were likely to engage with Royce Biopriting facilities in the future.
Interestingly the survey also demonstrated demand for further training in Stereolithography, Melt Electrospinning Writing and Ink Jet Printing.
Join us on the 30th November for our next event, to learn more about Royce national facilities in Biofabrication and 3D Printing, as well as to find out more about opportunities for access and collaboration.
Showcase: Biofabrication and 3D Printing for Biomedical Applications – Henry Royce Institute
